Clinical Trial Update: Initial Staging of Lobular Breast Carcinoma: Head to Head Comparison of 68Ga-FAPI-46 and 18F-FDG PET/CT [NA]

View source ↗

Summary

A clinical trial compares two PET imaging tracers, 68Ga-FAPI-46 and 18F-FDG, for initial staging of lobular breast carcinoma; the study is currently active but …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lobular Breast Carcinoma

Drugs mentioned

• 18F-FDG (fluorodeoxyglucose F-18)
• 68Ga-FAPI-46 (Gallium-68-labeled FAPI-46)

Snippet

Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer | Conditions: Lobular Breast Carcinoma | NA | Status: ACTIVE_NOT_RECRUITING